Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Dan

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Cancer Science|March 1, 2011
Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivoKazunori Anzai, Emiko Sekine-Suzuki, Megumi Ueno, et al.
International Journal of Clinical Oncology|October 15, 2014
Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristicsRie Horii, Masaaki Matsuura, Shingo Dan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissueYuko Sugiyama, Shingo Dan, Yoko Yoshida, et al.
Cancer Science|December 9, 2014
Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474Sho Isoyama, Gensei Kajiwara, Naomi Tamaki, et al.
Biochemistry|September 1, 2017
Family-wide Analysis of the Inhibition of Arf Guanine Nucleotide Exchange Factors with Small Molecules: Evidence of Unique Inhibitory ProfilesSarah Benabdi, François Peurois, Agata Nawrotek, et al.
Marine Drugs|July 17, 2014
In vitro antitumor activity of stellettin B, a triterpene from marine sponge Jaspis stellifera, on human glioblastoma cancer SF295 cellsSheng-An Tang, Qianxiang Zhou, Wen-Zhi Guo, et al.
Cancer Research|June 10, 2010
Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluationsShingo Dan, Mutsumi Okamura, Mariko Seki, et al.
The Journal of Antibiotics|December 7, 2021
Isolation of new derivatives of the 20-membered macrodiolide bispolide from Kitasatospora sp. MG372-hF19Yasuko Kohda, Shuichi Sakamoto, Maya Umekita, et al.
Oncotarget|May 12, 2016
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancerMitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, et al.
Cancer Research|May 20, 2016
M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric CancersYoshimi Ohashi, Mutsumi Okamura, Asaka Hirosawa, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Cancer Science|March 1, 2011
Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivoKazunori Anzai, Emiko Sekine-Suzuki, Megumi Ueno, et al.
International Journal of Clinical Oncology|October 15, 2014
Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristicsRie Horii, Masaaki Matsuura, Shingo Dan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissueYuko Sugiyama, Shingo Dan, Yoko Yoshida, et al.
Cancer Science|December 9, 2014
Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474Sho Isoyama, Gensei Kajiwara, Naomi Tamaki, et al.
Biochemistry|September 1, 2017
Family-wide Analysis of the Inhibition of Arf Guanine Nucleotide Exchange Factors with Small Molecules: Evidence of Unique Inhibitory ProfilesSarah Benabdi, François Peurois, Agata Nawrotek, et al.
Marine Drugs|July 17, 2014
In vitro antitumor activity of stellettin B, a triterpene from marine sponge Jaspis stellifera, on human glioblastoma cancer SF295 cellsSheng-An Tang, Qianxiang Zhou, Wen-Zhi Guo, et al.
Cancer Research|June 10, 2010
Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluationsShingo Dan, Mutsumi Okamura, Mariko Seki, et al.
The Journal of Antibiotics|December 7, 2021
Isolation of new derivatives of the 20-membered macrodiolide bispolide from Kitasatospora sp. MG372-hF19Yasuko Kohda, Shuichi Sakamoto, Maya Umekita, et al.
Oncotarget|May 12, 2016
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancerMitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, et al.
Cancer Research|May 20, 2016
M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric CancersYoshimi Ohashi, Mutsumi Okamura, Asaka Hirosawa, et al.
Pageof 9